What is GERD or Reflux
What is GERD or Reflux?
For infants and totlers, it is often called or referred to as reflux, short for the medical term gastroesophageal reflux (GER). It is a common condition in infants, and typically resolves between six and twelve months of age. Infants with reflux will often spit up after feeding, and have difficulties taking in enough nutrition. Many babies suffer from reflux, and rarely need treatment. Some, however, do receive Reglan for treatment.
For adults, the symptoms usually progress to a greater set of problems, such as chronic heartburn, decreased appetite, or the more difficult issues of constant nausea and vomiting. Treatment with Reglan is intended to last for 4 to 12 weeks. Many doctors are unaware of this recommendation, and end up prescribing Reglan for significantly longer periods. This can have terrible consequences for the patient.
As with any medication, a detailed risk/benefit discussion with your doctor is critical. Your prescribing medical professional must adequately explain the increased risk of tardive dyskinesia posed by use of Reglan, particularly with extended use. Since Reglan is only intended to be used for short-term relief of gastrointestinal problems when other treatments have failed, the risks associated with long term use are very serious. Failure to properly monitor the duration of use, or the over prescribing of the medicine, may be negligent on the part of the physician.
TRADEMARK NOTICE: Reglan is a trademark of Schwarz Pharma.
The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Schwarz Pharma. The use of this mark is solely for informational and product identification purposes.
For infants and totlers, it is often called or referred to as reflux, short for the medical term gastroesophageal reflux (GER). It is a common condition in infants, and typically resolves between six and twelve months of age. Infants with reflux will often spit up after feeding, and have difficulties taking in enough nutrition. Many babies suffer from reflux, and rarely need treatment. Some, however, do receive Reglan for treatment.
For adults, the symptoms usually progress to a greater set of problems, such as chronic heartburn, decreased appetite, or the more difficult issues of constant nausea and vomiting. Treatment with Reglan is intended to last for 4 to 12 weeks. Many doctors are unaware of this recommendation, and end up prescribing Reglan for significantly longer periods. This can have terrible consequences for the patient.
As with any medication, a detailed risk/benefit discussion with your doctor is critical. Your prescribing medical professional must adequately explain the increased risk of tardive dyskinesia posed by use of Reglan, particularly with extended use. Since Reglan is only intended to be used for short-term relief of gastrointestinal problems when other treatments have failed, the risks associated with long term use are very serious. Failure to properly monitor the duration of use, or the over prescribing of the medicine, may be negligent on the part of the physician.
TRADEMARK NOTICE: Reglan is a trademark of Schwarz Pharma.
The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Schwarz Pharma. The use of this mark is solely for informational and product identification purposes.
